These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23985780)

  • 1. Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
    Chik F; Machnes Z; Szyf M
    Carcinogenesis; 2014 Jan; 35(1):138-44. PubMed ID: 23985780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.
    Chik F; Szyf M
    Carcinogenesis; 2011 Feb; 32(2):224-32. PubMed ID: 20980350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
    Primeau M; Gagnon J; Momparler RL
    Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A; Momparler RL
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer.
    Hussain Z; Khan MI; Shahid M; Almajhdi FN
    Genet Mol Res; 2013 Apr; 12(2):1106-18. PubMed ID: 23661436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
    Singh KP; Treas J; Tyagi T; Gao W
    Cancer Lett; 2012 Mar; 316(1):62-9. PubMed ID: 22082530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
    Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
    Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
    Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM
    Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.
    Cheishvili D; Chik F; Li CC; Bhattacharya B; Suderman M; Arakelian A; Hallett M; Rabbani SA; Szyf M
    Carcinogenesis; 2014 Nov; 35(11):2436-46. PubMed ID: 25178277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
    Segura-Pacheco B; Trejo-Becerril C; Perez-Cardenas E; Taja-Chayeb L; Mariscal I; Chavez A; Acuña C; Salazar AM; Lizano M; Dueñas-Gonzalez A
    Clin Cancer Res; 2003 May; 9(5):1596-603. PubMed ID: 12738711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs.
    Charlet J; Schnekenburger M; Brown KW; Diederich M
    Biochem Pharmacol; 2012 Apr; 83(7):858-65. PubMed ID: 22280814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
    Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
    Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
    Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
    Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation of DNA by decitabine in cancer chemotherapy.
    Brown R; Plumb JA
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):501-10. PubMed ID: 15270655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.